期刊
AMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE
卷 39, 期 2, 页码 211-219出版社
SAGE PUBLICATIONS INC
DOI: 10.1177/10499091211018664
关键词
interstitial lung disease; idiopathic pulmonary fibrosis; specialist palliative care; opioids; symptomatic care; qualitative research
资金
- Australian National Health and Medical Research Council (Emerging Leader Investigator grant)
- Windermere Foundation VALE research fellowship
This study explored clinicians' perspectives on specialist palliative care and opioids for interstitial lung disease patients, highlighting barriers such as stigmatized beliefs and difficulties navigating the healthcare system. Early implementation of specialist palliative care and symptom palliation were deemed crucial for alleviating symptoms, providing emotional support, and enhancing quality of life by the participants. Trust in therapeutic relationships and strong interdisciplinary partnerships were seen as key in improving patient access to symptom palliation.
Objectives: Interstitial lung disease (ILD) is a debilitating and life-limiting condition, requiring multi-disciplinary care. While guidelines recommend early specialist palliative care referral to improve symptoms and quality of life, few patients access such care towards the end-of-life. This study aimed to explore clinicians' perspectives regarding specialist palliative care and opioids to understand barriers to optimal care and guide clinical practice improvement initiatives. Methods: A cross-sectional, exploratory, qualitative study was undertaken with Australian respiratory clinicians caring for people with ILD (n = 17). In-depth, semi-structured interviews were audio-recorded, transcribed verbatim and coded. Thematic analysis was undertaken to extrapolate recurring ideas from the data. Results: Four themes were identified: 1) understanding how to improve patient care and support, 2) the need to dispel stigmatized beliefs and misconceptions, 3) the importance of trusted relationships and good communication and 4) the challenges of navigating the health-care system. Participants discussed the need to implement early specialist palliative care and symptom palliation to alleviate symptoms, provide emotional support and augment quality of life. Participants described challenges accessing palliative care and opioids due to stigmatized beliefs amongst patients and clinicians and difficulties navigating the health-care system. Trusted therapeutic relationships with patients and strong inter-disciplinary partnerships with collaborative education and communication were perceived to improve patients' access to symptom palliation. Conclusion: Specialist palliative care and opioids were believed to improve patients' quality of life, however, many barriers can make accessing such care challenging. To address these issues, multi-disciplinary collaboration, high-quality communication and trusted therapeutic relationships are crucial throughout the ILD illness journey.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据